Your browser doesn't support javascript.
loading
Safety and Dosing Study of a Cholecystokinin Receptor Antagonist in Non-alcoholic Steatohepatitis.
Rabiee, Atoosa; Gay, Martha D; Shivapurkar, Narayan; Cao, Hong; Nadella, Sandeep; Smith, Coleman I; Lewis, James H; Bansal, Sunil; Cheema, Amrita; Kwagyan, John; Smith, Jill P.
Afiliação
  • Rabiee A; Department of Medicine, Washington DC Veterans Affairs Medical Center, Washington, DC, USA.
  • Gay MD; Department of Medicine, Georgetown University Medical Center, Washington, DC, USA.
  • Shivapurkar N; Department of Medicine, Georgetown University Medical Center, Washington, DC, USA.
  • Cao H; Department of Medicine, Georgetown University Medical Center, Washington, DC, USA.
  • Nadella S; Departments of Gastroenterology and Transplant Surgery, MedStar Georgetown University Hospital, Washington, DC, USA.
  • Smith CI; Departments of Gastroenterology and Transplant Surgery, MedStar Georgetown University Hospital, Washington, DC, USA.
  • Lewis JH; Departments of Gastroenterology and Transplant Surgery, MedStar Georgetown University Hospital, Washington, DC, USA.
  • Bansal S; Department of Medicine, Georgetown University Medical Center, Washington, DC, USA.
  • Cheema A; Department of Medicine, Georgetown University Medical Center, Washington, DC, USA.
  • Kwagyan J; Department of Statistics, Howard University, Washington, DC, USA.
  • Smith JP; Department of Medicine, Washington DC Veterans Affairs Medical Center, Washington, DC, USA.
Clin Pharmacol Ther ; 112(6): 1271-1279, 2022 12.
Article em En | MEDLINE | ID: mdl-36087237

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos